Advanced search
Publication Cover
Renal Failure Volume 40, 2018 - Issue 1
Submit an article Journal homepage
1,143
Views
7
CrossRef citations to date
0
Altmetric
Brief Report

Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase

Dominika WójtowiczPathophysiology Unit, Department of Pathophysiology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland;
,
Dominika CholewaPathophysiology Unit, Department of Pathophysiology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland;
,
Anna M. FabaPathophysiology Unit, Department of Pathophysiology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland;
,
Beata DomańskaPathophysiology Unit, Department of Pathophysiology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland;
,
Joanna KokoszkaPathophysiology Unit, Department of Pathophysiology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland;
,
Konrad KopaczPathophysiology Unit, Department of Pathophysiology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland;
,
Rafał FicekDialysis Center in Katowice "NEFROMED", Centrum Dializa Sosnowiec, Katowice, Poland; ;Department of Nephrology, Transplantation and Internal Medicine, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland; ORCID Iconhttp://orcid.org/0000-0002-8230-5101
ORCID Icon,
Tomasz IrzyniecDepartment of Nephrology with Dialysis Unit, MSWiA Hospital, Katowice, Poland; ;Department of Health Promotion and Community Nursing, School of Health Sciences, Medical University of Silesia in Katowice, Katowice, Poland;
,
Sylwia E. RotkegelDialysis Center in Katowice "NEFROMED", Centrum Dializa Sosnowiec, Katowice, Poland;
&
Jerzy ChudekPathophysiology Unit, Department of Pathophysiology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland; ;Dialysis Center in Katowice "NEFROMED", Centrum Dializa Sosnowiec, Katowice, Poland; ;Department of Internal Medicine and Oncological Chemotherapy, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, PolandCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6367-7794
ORCID Icon show all
Pages 384-389 | Received 24 Nov 2017, Accepted 07 Jun 2018, Published online: 16 Jul 2018

References

  • Little MA, Walshe JJ. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction. Am J Kidney Dis. 2002;39:86–91.
  • Napalkov P, Felici DM, Chu LK, et al. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis. BMC Cardiovasc Disord. 2013;13:86.
  • Beathard GA. Catheter thrombosis. Semin Dial. 2001;14:441–445.
  • Gallieni M, Giordano A, Rossi U, et al. Optimization of dialysis catheter function. J Vasc Access. 2016;17:42–46.
  • McFarland HF, Dinwiddie L, Ferrell J, et al. Lytic therapy in central venous catheters for hemodialysis. Nephrol Nurs J. 2002;29:355–360. quiz 361–362
  • Mendes ML, Barretti P, da Silva TNV, et al. Approach to thrombotic occlusion related to long-term catheters of hemodialysis patients: a narrative review. J Bras Nefrol. 2015;37:221–227.
  • Zacharias JM, Weatherston CP, Spewak CR, et al. Alteplase versus urokinase for occluded hemodialysis catheters. Ann Pharmacother. 2003;37:27–33.
  • NKF-K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations 2006 Updates, Hemodialysis Adequacy, Peritoneal Dialysis Adequacy, Vascular. [cited 2017 Apr 12] http://www2.kidney.org/professionals/kdoqi/guideline_uphd_pd_va/va_guide7.htm
  • Shavit L, Lifschitz M, Plaksin J, et al. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients. Clin Nephrol. 2010;74:297–302.
  • Pollo V, Dionizio D, Bucuvic EM, et al. Alteplase vs. urokinase for occluded hemodialysis catheter: a randomized trial. Hemodialysis Int. 2016;20:378–384.
  • Androulakis NE, Tzenakis N, Nioti E, et al. Activated protein C-resistance determination and vascular access thrombosis in populations with high prevalence of factor V Leiden. Nephron. 2015;131:5–10.
  • Moist LM, Hemmelgarn BR, Lok CE. Relationship between blood flow in central venous catheters and hemodialysis adequacy. Clin J Am Soc Nephrol. 2006;1:965–971.
  • Westein E, Hoefer T, Calkin AC. Thrombosis in diabetes: a shear flow effect? Clin Sci. 2017;131:1245–1260.
  • Agarwal AK, Patel BM, Haddad NJ. Central vein stenosis: a nephrologist’s perspective. Semin Dial. 2007;20:53–62.
  • Fortes PC, Mendes JG, Sesiuk K, et al. Glycemic and lipidic profile in diabetic patients undergoing dialysis. Arq Bras Endocrinol Metab. 2010;54:793–800.
  • Kinalska I, Telejko B. Recent progress in diabetic trombophilia prophylaxis and treatment. Diabetologia Praktyczna. 2003;4:153–160.
  • Hemmelgarn BR, Moist LM, Lok CE, et al. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med. 2011;364:303–312.
  • Mokrzycki MH, Jean-Jerome K, Rush H, et al. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int. 2001;59:1935–1942.
  • Wang AY, Ivany JN, Perkovic V, et al. Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials. Nephrol Dial Transplant. 2013;28:2875–2888.
  • Willms L, Vercaigne LM. Does warfarin safely prevent clotting of hemodialysis catheters? A review of efficacy and safety. Semin Dial. 2008;21:71–77.
  • Vlachopanos G, Ghalli FG. Antithrombotic medications in dialysis patients: a double-edged sword. J Evid Based Med. 2017;10:53–60.
  • Zellweger M, Bouchard J, Raymond-Carrier S, et al. Systemic anticoagulation and prevention of hemodialysis catheter malfunction. ASAIO J. 2005;51:360–365.
  • Bonkain F, Van Hulle F, Janssens P, et al. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial. J Vasc Access. 2017;18:436–442.
  • Zawilska K. Hereditary thrombophilia and venous thromboembolism. Hematologia. 2013;4:35–42.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.